Author: Laing, Lizahn
Author: Semere, Gebreyesus Manna
Similar Items: The characterization of pharmacokinetic properties and evaluation of in vitro drug combination efficacies of novel antimalarial compounds
- Impactful maps and associated visualisations on antimalarial drug resistance for malaria programmes and policymakers
- In vitro antimalarial activity of ethnobotanically selected indigenous plants and characterisation of a bioactive compound
- DETERMINANTS OF RESPONSES TO ANTIMALARIAL DRUGS IN CHILDREN WITH UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA
- Safety of antimalarial drugs exposure during early pregnancy
- Investigations into the Peroxidase Activity of Ferriprotoporphyrin IX and its Complexes with Clinically Relevant Antimalarial Drugs
- Interactions of quinoline antimalarial drugs with ferrihaem : structural and kinetic insights into the inhibition of malaria pigment formation
Similar Items: Population pharmacokinetic modelling for dose optimization of esomeprazole to treat early-onset preeclampsia
- Population pharmacokinetics and pharmacokinetic-pharmacodyamic modeling of antitubercular drugs
- The pharmacokinetics of lopinavir in HIV-infected adults receiving rifampicin with adjusted doses of lopinavir
- Population pharmacokinetic and pharmacodynamic modelling to improve tuberculosis treatment
- Population pharmacokinetic modelling to address the gaps in knowledge of commonly used HIV and TB drugs in children
- The Preeclampsia intervention with Esomeprazole (PIE) trial: A double blind, randomised, placebo-controlled trial to treat early onset severe preeclampsia
- Characterizing population pharmacokinetic/pharmacodynamic relationships in pulmonary tuberculosis infected adults using nonlinear mixed effects modelling